Do calcium carbonate (Tums) or famotidine (Pepcid) reduce warfarin absorption?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 6, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

No, Tums and Pepcid Do Not Reduce Warfarin Absorption

Neither calcium carbonate (Tums) nor famotidine (Pepcid) reduce warfarin absorption or interfere with its anticoagulant effect. These medications can be safely used together with warfarin without dose adjustments or special monitoring beyond routine INR checks.

Evidence for Famotidine (Pepcid)

Famotidine has been specifically studied and shown to have no interaction with warfarin. A controlled study in healthy volunteers taking warfarin demonstrated that famotidine 40 mg daily for 7 days did not alter prothrombin time, coagulation parameters, or warfarin plasma concentrations 1. Additional research confirmed that famotidine does not affect the cytochrome P450 enzyme system that metabolizes warfarin, unlike cimetidine which does cause significant interactions 2, 3.

The key distinction here is that famotidine is not cimetidine—while cimetidine (Tagamet) is notorious for drug interactions through CYP450 inhibition, famotidine has a completely different pharmacologic profile and does not share this property.

Evidence for Calcium Carbonate (Tums)

The comprehensive 2022 guideline on drug interactions affecting oral anticoagulants 4 does not list calcium carbonate or antacids as interacting with warfarin. This guideline extensively details medications that interfere with warfarin through various mechanisms including:

  • Absorption interference: Only bile acid sequestrants (cholestyramine) are noted to interfere with warfarin absorption, requiring spacing of administration
  • CYP450 interactions: Multiple drugs affecting warfarin metabolism are discussed
  • Protein binding displacement: Various medications that displace warfarin from albumin

Calcium carbonate is conspicuously absent from all these categories, indicating no clinically significant interaction.

Clinical Implications

  • No dose adjustment needed: Continue warfarin at the same dose when starting Tums or Pepcid
  • No special timing required: Unlike cholestyramine, these medications do not need to be separated from warfarin dosing
  • Standard INR monitoring: Continue routine INR checks as scheduled; no additional monitoring is necessary when adding these medications

Common Pitfall to Avoid

Do not confuse famotidine with cimetidine. Cimetidine significantly potentiates warfarin through CYP2C9 inhibition and requires warfarin dose reduction. If a patient mentions they're taking "an H2 blocker," specifically identify which one—famotidine and ranitidine are safe, but cimetidine is not 2.

References

Research

Lack of interaction between famotidine and warfarin.

International journal of clinical pharmacology research, 1990

Research

Comparative effects of H2-receptor antagonists on drug interaction in rats.

Drug metabolism and disposition: the biological fate of chemicals, 1986

Research

Pharmacodynamics of famotidine in humans.

The American journal of medicine, 1986

Guideline

drug interactions affecting oral anticoagulant use.

Circulation: Arrhythmia and Electrophysiology, 2022

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.